Announcement • Mar 04
GeneBioTech Co. ,Ltd, Annual General Meeting, Mar 26, 2026 GeneBioTech Co. ,Ltd, Annual General Meeting, Mar 26, 2026, at 09:00 Tokyo Standard Time. Location: conference room, 489, yeonggyudaesa-ro, gyeryong-myeon, chungcheongnam-do, gongju South Korea Announcement • Feb 10
GeneBioTech Co. ,Ltd announces Annual dividend GeneBioTech Co.,Ltd announced Annual dividend of KRW 50.0000 per share, ex-date on December 29, 2025 and record date on December 31, 2025. New Risk • Feb 09
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 1.1% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩39.6b market cap, or US$27.1m).